miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma
Stark, Mitchell S, Bonazzi, Vanessa F, Boyle, Glen M, Palmer, Jane M, Symmons, Judith, Lanagan, Catherine M, Schmidt, Christopher W, Herington, Adrian C, Ballotti, Robert, Pollock, Pamela M, Hayward, Nicholas K
Published in Oncotarget (10.07.2015)
Published in Oncotarget (10.07.2015)
Get full text
Journal Article
Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing
Stark, Mitchell S, Woods, Susan L, Gartside, Michael G, Bonazzi, Vanessa F, Dutton-Regester, Ken, Aoude, Lauren G, Chow, Donald, Sereduk, Chris, Niemi, Natalie M, Tang, Nanyun, Ellis, Jonathan J, Reid, Jeffrey, Zismann, Victoria, Tyagi, Sonika, Muzny, Donna, Newsham, Irene, Wu, YuanQing, Palmer, Jane M, Pollak, Thomas, Youngkin, David, Brooks, Bradford R, Lanagan, Catherine, Schmidt, Christopher W, Kobe, Bostjan, MacKeigan, Jeffrey P, Yin, Hongwei, Brown, Kevin M, Gibbs, Richard, Trent, Jeffrey, Hayward, Nicholas K
Published in Nature genetics (01.02.2012)
Published in Nature genetics (01.02.2012)
Get full text
Journal Article
The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence
Atkinson, Caroline, McInerney-Leo, Aideen M, Proctor, Martina, Lanagan, Catherine, Stevenson, Alexander J, Dehkhoda, Farhad, Caole, Mary, Maas, Ellie, Ainger, Stephen, Pritchard, Antonia L, Johansson, Peter A, Leo, Paul, Hayward, Nicholas K, Sturm, Richard A, Duncan, Emma L, Gabrielli, Brian
Published in International journal of molecular sciences (01.02.2024)
Published in International journal of molecular sciences (01.02.2024)
Get full text
Journal Article
Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In Vivo
Oo, Zay Yar, Stevenson, Alexander J, Proctor, Martina, Daignault, Sheena M, Walpole, Sebastian, Lanagan, Catherine, Chen, James, Škalamera, Dubravka, Spoerri, Loredana, Ainger, Stephen A, Sturm, Richard A, Haass, Nikolas K, Gabrielli, Brian
Published in Clinical cancer research (15.06.2018)
Published in Clinical cancer research (15.06.2018)
Get full text
Journal Article
Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine
Oo, Zay Yar, Proctor, Martina, Stevenson, Alexander J., Nazareth, Deborah, Fernando, Madushan, Daignault, Sheena M., Lanagan, Catherine, Walpole, Sebastian, Bonazzi, Vanessa, Škalamera, Dubravka, Snell, Cameron, Haass, Nikolas K., Larsen, Jill E., Gabrielli, Brian
Published in Molecular oncology (01.07.2019)
Published in Molecular oncology (01.07.2019)
Get full text
Journal Article
Dendritic cell immunotherapy for stage IV melanoma
O'Rourke, Michael G E, Johnson, Maree K, Lanagan, Catherine M, See, Janet L, O'Connor, Linda E, Slater, Gregory J, Thomas, David, Lopez, José Alejandro, Martinez, Nathan R, Ellem, Kay A O, Schmidt, Christopher W
Published in Melanoma research (01.10.2007)
Published in Melanoma research (01.10.2007)
Get more information
Journal Article
Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma
Marshall, Julia A, Forster, Trevor H, Purdie, David M, Lanagan, Catherine M, O'Connor, Linda E, O'rourke, Michael GE, Johnson, Maree K, See, Janet L, Ellem, Kay AO, Martinez, Nathan R, López, J Alejandro, Schmidt, Christopher W
Published in Immunology and cell biology (01.06.2006)
Published in Immunology and cell biology (01.06.2006)
Get full text
Journal Article
Melanoma mutations modify melanocyte dynamics in co-culture with keratinocytes or fibroblasts
Škalamera, Dubravka, Stevenson, Alexander J, Ehmann, Anna, Ainger, Stephen A, Lanagan, Catherine, Sturm, Richard A, Gabrielli, Brian
Published in Journal of cell science (15.12.2019)
Published in Journal of cell science (15.12.2019)
Get full text
Journal Article
Abstract A33: Defect in S phase cell cycle checkpoint renders tumours vulnerable to CHK1 inhibitor single-agent treatment in vitro and in vivo
Oo, Zay Yar, Stevenson, Alexander, Lanagan, Catherine, Spoerri, Loredana, Larsen, Jill, Gabrielli, Brian
Published in Molecular cancer research (01.04.2017)
Published in Molecular cancer research (01.04.2017)
Get full text
Journal Article
Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine
O'ROURKE, Michael G. E, JOHNSON, Maree, ELLIOTT, Suzanne L, ELLEM, Kay A. O, SCHMIDT, Christopher W, LANAGAN, Catherine, SEE, Janet, JIE YANG, BELL, John R, SLATER, Greg J, KERR, Beverley M, CROWE, Beth, PURDIE, David M
Published in Cancer Immunology, Immunotherapy (01.06.2003)
Published in Cancer Immunology, Immunotherapy (01.06.2003)
Get full text
Journal Article
Frequent somatic MAP3K5 and MAP3K9 mutations in metastatic melanoma identified by exome sequencing
Stark, Mitchell S, Woods, Susan L, Gartside, Michael G, Bonazzi, Vanessa F, Dutton-Regester, Ken, Aoude, Lauren G, Chow, Donald, Sereduk, Chris, Niemi, Natalie M, Tang, Nanyun, Ellis, Jonathan J, Reid, Jeffrey, Zismann, Victoria, Tyagi, Sonika, Muzny, Donna, Newsham, Irene, Wu, YuanQing, Palmer, Jane M, Pollak, Thomas, Youngkin, David, Brooks, Bradford R, Lanagan, Catherine, Schmidt, Christopher W, Kobe, Bostjan, MacKeigan, Jeffrey P, Yin, Hongwei, Brown, Kevin M, Gibbs, Richard, Trent, Jeffrey, Hayward, Nicholas K
Published in Nature genetics (25.12.2011)
Published in Nature genetics (25.12.2011)
Get full text
Journal Article